Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

NCT01638858 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Lucentis (Ranibizumab)

Sponsor

University of Luebeck